May. 29 at 1:55 PM
$CNXU — REGENERATIVE MEDICINE PLATFORM + TISSUE REGENERATION 👇
Conexeu Sciences is changing the game in surgery. Instead of permanent implants, they’ve developed a collagen scaffold that helps your body grow its own living tissue back. It’s a versatile, IP-protected platform for wound care and reconstruction.
What’s standing out:
🔹 One Platform: Tech scales from wound care to 3D-printed breast reconstruction.
Partnerships: Teaming up with Wake Forest (WFIRM) on the B.R.E.A.S.T.™ program.
🔹 Clean IP: Patents held globally with no royalty burdens.
🔹 Clear Path: Targeting 510(k) approval by early 2027.
Communicated Disclaimer - https://stockresearchtoday.com/cnxu/
$PRFX $REPL $GOVX
